Drug Database
Back to search

Netherlands· NL-286186baa86f

Recarbrio 500 mg/500 mg/250 mg, poeder voor oplossing voor infusie

A imipenem, cilastatin and relebactam product containing cilastatine natrium + imipenem 1-water + relebactam 1-water, registered in Netherlands by Merck Sharp & Dohme B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC J01DH56

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedRecarbrio 500 mg/500 mg/250 mg, poede…ATCJ01DH56REGISTER NO.NL-286186baa86fPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cilastatine natrium + imipenem 1-water + relebactam 1-waterAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Imipenem, cilastatin and relebactam is registered in 11 of 19 countries.

Countries holding a registration under ATC J01DH56 (imipenem, cilastatin and relebactam), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search imipenem, cilastatin and relebactam products by name

Imipenem, cilastatin and relebactam · ATC J01DH56

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CILASTATINE NATRIUM + IMIPENEM 1-WATER + RELEBACTAM 1-WATER
Manufacturer
Merck Sharp & Dohme B.V.
Country
Netherlands (NL)
ATC code
J01DH56
ATC class
Imipenem, cilastatin and relebactam
Defined daily dose
2 g, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/19/1420

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Imipenem, cilastatin and relebactam in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All imipenem, cilastatin and relebactam products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Recarbrio
  • Liechtenstein · Recarbrio
  • Norway · Recarbrio

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8e2a69e7-2e0a-4723-a9f7-ee3f12d08794
GET /v1/drugs/8e2a69e7-2e0a-4723-a9f7-ee3f12d08794?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/recarbrio-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Imipenem, Cilastatin And Relebactam",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp124113",
  "excipients": [
    "NATRIUMWATERSTOFCARBONAAT (E 500 (II))",
    "STIKSTOF (HEAD SPACE) (E 941)"
  ],
  "substances": [
    "CILASTATINE NATRIUM",
    "IMIPENEM 1-WATER",
    "RELEBACTAM 1-WATER"
  ],
  "leaflet_url": null,
  "authorised_at": "2020/02/13",
  "procedure_number": "EMEA/H/C/004808",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/19/1420",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about imipenem, cilastatin and relebactam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console